🎉 M&A multiples are live!
Check it out!

Boiron Valuation Multiples

Discover revenue and EBITDA valuation multiples for Boiron and similar public comparables like Pharming, Julphar, and Galapagos.

Boiron Overview

About Boiron

Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company’s products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.


Founded

1932

HQ

France
Employees

2.8K+

Website

boiron.com

Financials

LTM Revenue $529M

LTM EBITDA $79.6M

EV

$401M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Boiron Financials

Boiron has a last 12-month revenue of $529M and a last 12-month EBITDA of $79.6M.

In the most recent fiscal year, Boiron achieved revenue of $530M and an EBITDA of $79.1M.

Boiron expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Boiron valuation multiples based on analyst estimates

Boiron P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $574M $530M XXX XXX XXX
Gross Profit $352M $408M XXX XXX XXX
Gross Margin 61% 77% XXX XXX XXX
EBITDA $82.7M $79.1M XXX XXX XXX
EBITDA Margin 14% 15% XXX XXX XXX
Net Profit $30.7M $48.0M XXX XXX XXX
Net Margin 5% 9% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Boiron Stock Performance

As of April 15, 2025, Boiron's stock price is EUR 24 (or $25).

Boiron has current market cap of EUR 411M (or $442M), and EV of EUR 373M (or $401M).

See Boiron trading valuation data

Boiron Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$401M $442M XXX XXX XXX XXX $0.98

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Boiron Valuation Multiples

As of April 15, 2025, Boiron has market cap of $442M and EV of $401M.

Boiron's trades at 0.8x LTM EV/Revenue multiple, and 5.0x LTM EBITDA.

Analysts estimate Boiron's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Boiron and 10K+ public comps

Boiron Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $401M XXX XXX XXX
EV/Revenue 0.8x XXX XXX XXX
EV/EBITDA 5.1x XXX XXX XXX
P/E 11.5x XXX XXX XXX
P/E/Growth 34.5x XXX XXX XXX
EV/FCF 13.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Boiron Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Boiron Valuation Multiples

Boiron's NTM/LTM revenue growth is 3%

Boiron's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Boiron's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Boiron's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Boiron and other 10K+ public comps

Boiron Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -8% XXX XXX XXX XXX
EBITDA Margin 15% XXX XXX XXX XXX
EBITDA Growth -4% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 18% XXX XXX XXX XXX
Revenue per Employee $0.2M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue 47% XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 1% XXX XXX XXX XXX
Opex to Revenue 64% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Boiron Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Boiron M&A and Investment Activity

Boiron acquired  XXX companies to date.

Last acquisition by Boiron was  XXXXXXXX, XXXXX XXXXX XXXXXX . Boiron acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Boiron

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Boiron

When was Boiron founded? Boiron was founded in 1932.
Where is Boiron headquartered? Boiron is headquartered in France.
How many employees does Boiron have? As of today, Boiron has 2.8K+ employees.
Is Boiron publicy listed? Yes, Boiron is a public company listed on PAR.
What is the stock symbol of Boiron? Boiron trades under BOI ticker.
When did Boiron go public? Boiron went public in 1989.
Who are competitors of Boiron? Similar companies to Boiron include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Boiron? Boiron's current market cap is $442M
What is the current revenue of Boiron? Boiron's last 12-month revenue is $529M.
What is the current EBITDA of Boiron? Boiron's last 12-month EBITDA is $79.6M.
What is the current EV/Revenue multiple of Boiron? Current revenue multiple of Boiron is 0.8x.
What is the current EV/EBITDA multiple of Boiron? Current EBITDA multiple of Boiron is 5.0x.
What is the current revenue growth of Boiron? Boiron revenue growth between 2023 and 2024 was -8%.
Is Boiron profitable? Yes, Boiron is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.